These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 24328568

  • 1. Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology.
    Sahmay S, Aydın Y, Atakul N, Aydogan B, Kaleli S.
    Gynecol Endocrinol; 2014 Feb; 30(2):130-4. PubMed ID: 24328568
    [Abstract] [Full Text] [Related]

  • 2. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R.
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
    [Abstract] [Full Text] [Related]

  • 3. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 4. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
    [Abstract] [Full Text] [Related]

  • 5. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Sep; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 6. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [Abstract] [Full Text] [Related]

  • 7. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P, Kulkarni A, Dilgil M, Dhir P, Shah A, Gudi A, Homburg R.
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [Abstract] [Full Text] [Related]

  • 9. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 10. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 11. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Aug 01; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 12. The role of antimullerian hormone in the hormonal workup of women with persistent acne.
    Sardana K, Singh C, Narang I, Bansal S, Garg VK.
    J Cosmet Dermatol; 2016 Dec 01; 15(4):343-349. PubMed ID: 27320497
    [Abstract] [Full Text] [Related]

  • 13. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep 01; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 14. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 01; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

  • 15. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries.
    Rosenfield RL, Wroblewski K, Padmanabhan V, Littlejohn E, Mortensen M, Ehrmann DA.
    Fertil Steril; 2012 Jul 01; 98(1):242-9. PubMed ID: 22541936
    [Abstract] [Full Text] [Related]

  • 16. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 01; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 17. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
    Yang Z, Zhou W, Zhou C, Zhou Y, Liu X, Ding G, Hu Y, Pan J, Sheng J, Jin L, Huang H.
    J Steroid Biochem Mol Biol; 2021 Feb 01; 206():105806. PubMed ID: 33340681
    [Abstract] [Full Text] [Related]

  • 18. Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.
    Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, Smolarczyk R.
    Int J Mol Sci; 2021 Nov 19; 22(22):. PubMed ID: 34830389
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone.
    Villarroel C, Merino PM, López P, Eyzaguirre FC, Van Velzen A, Iñiguez G, Codner E.
    Hum Reprod; 2011 Oct 19; 26(10):2861-8. PubMed ID: 21784736
    [Abstract] [Full Text] [Related]

  • 20. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 19; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.